ATHE
Price
$3.42
Change
+$0.06 (+1.79%)
Updated
Jan 17 closing price
Capitalization
27.69M
CTCX
Price
$0.53
Change
-$0.04 (-7.02%)
Updated
Jan 17 closing price
Capitalization
15.82M
Ad is loading...

ATHE vs CTCX

Header iconATHE vs CTCX Comparison
Open Charts ATHE vs CTCXBanner chart's image
Alterity Therapeutics
Price$3.42
Change+$0.06 (+1.79%)
Volume$18.51K
Capitalization27.69M
Carmell
Price$0.53
Change-$0.04 (-7.02%)
Volume$273.61K
Capitalization15.82M
ATHE vs CTCX Comparison Chart
Loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. CTCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Hold and CTCX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATHE: $3.42 vs. CTCX: $0.53)
Brand notoriety: ATHE and CTCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 20% vs. CTCX: 3%
Market capitalization -- ATHE: $27.69M vs. CTCX: $15.82M
ATHE [@Biotechnology] is valued at $27.69M. CTCX’s [@Biotechnology] market capitalization is $15.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileCTCX’s FA Score has 1 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • CTCX’s FA Score: 1 green, 4 red.
According to our system of comparison, CTCX is a better buy in the long-term than ATHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 3 TA indicator(s) are bullish while CTCX’s TA Score has 6 bullish TA indicator(s).

  • ATHE’s TA Score: 3 bullish, 5 bearish.
  • CTCX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CTCX is a better buy in the short-term than ATHE.

Price Growth

ATHE (@Biotechnology) experienced а +2.40% price change this week, while CTCX (@Biotechnology) price change was +6.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ATHE is expected to report earnings on May 31, 2023.

CTCX is expected to report earnings on Mar 17, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHE($27.7M) has a higher market cap than CTCX($15.8M). CTCX YTD gains are higher at: 88.176 vs. ATHE (3.323).
ATHECTCXATHE / CTCX
Capitalization27.7M15.8M175%
EBITDAN/A-9.47M-
Gain YTD3.32388.1764%
P/E RatioN/A1.09-
RevenueN/A32.8K-
Total CashN/A1.14M-
Total DebtN/A782K-
FUNDAMENTALS RATINGS
ATHE: Fundamental Ratings
ATHE
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHECTCX
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
30%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
36%
Momentum
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
29%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
41%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
33%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
26%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
Bullish Trend 5 days ago
48%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
30%
Aroon
ODDS (%)
Bullish Trend 5 days ago
68%
N/A
View a ticker or compare two or three
Ad is loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
+1.79%
EYPT - ATHE
54%
Loosely correlated
+2.89%
KALA - ATHE
41%
Loosely correlated
+3.42%
GLMD - ATHE
31%
Poorly correlated
-1.02%
RXRX - ATHE
30%
Poorly correlated
+2.03%
CVM - ATHE
30%
Poorly correlated
+0.90%
More

CTCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTCX has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CTCX jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTCX
1D Price
Change %
CTCX100%
-8.66%
RAIN - CTCX
53%
Loosely correlated
+7.73%
ATNF - CTCX
36%
Loosely correlated
-1.27%
PHMMF - CTCX
30%
Poorly correlated
N/A
INKT - CTCX
28%
Poorly correlated
+5.77%
ATHE - CTCX
27%
Poorly correlated
+1.79%
More